Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

398 ARTÍCULOS , VIENDO DEL 16 AL 30

Current Progress on Peroxisome Proliferator-activated Receptor Gamma Agonist as an Emerging Therapeutic Approach for the Treatment of Alzheimer's Disease: An Update

Khan MA, Alam Q, Haque A, Ashafaq M, Khan MJ, Ashraf GM, Ahmad M.

Curr Neuropharmacol. 2019;17(3):232-246. doi: 10.2174/1570159X16666180828100002.

Supranutritional Sodium Selenate Supplementation Delivers Selenium to the Central Nervous System: Results from a Randomized Controlled Pilot Trial in Alzheimer's Disease

Cardoso BR, Roberts BR, Malpas CB, Vivash L, Genc S, Saling MM, Desmond P, Steward C, Hicks RJ, Callahan J, Brodtmann A, Collins S, Macfarlane S, Corcoran NM, Hovens CM, Velakoulis D, O'Brien TJ, Hare DJ, Bush AI.

Neurotherapeutics. 2019 Jan;16(1):192-202. doi: 10.1007/s13311-018-0662-z.

Alzheimer's Disease - Future Therapy Based on Dendrimers

Aliev G, Ashraf GM, Tarasov VV, Chubarev VN, Leszek J, Gasiorowski K, Makhmutovа A, Baeesa SS, Avila-Rodriguez M, Ustyugov AA, Bachurin SO.

Curr Neuropharmacol. 2019;17(3):288-294. doi: 10.2174/1570159X16666180918164623.

Curcuminoids and Novel Opportunities for the Treatment of Alzheimer's Disease: Which Molecules are Actually Effective?

Zholos AV, Moroz OF, Storozhuk MV.

Curr Mol Pharmacol. 2019;12(1):12-26. doi: 10.2174/1874467211666181012150847.

Safety, Tolerability, and Feasibility of Young Plasma Infusion in the Plasma for Alzheimer Symptom Amelioration Study: A Randomized Clinical Trial

Sha SJ, Deutsch GK, Tian L, Richardson K, Coburn M, Gaudioso JL, Marcal T, Solomon E, Boumis A, Bet A, Mennes M, van Oort E, Beckmann CF, Braithwaite SP, Jackson S, Nikolich K, Stephens D, Kerchner GA, Wyss-Coray T.

JAMA Neurol. 2019 Jan 1;76(1):35-40. doi: 10.1001/jamaneurol.2018.3288.

Extending Arms of Insulin Resistance from Diabetes to Alzheimer's Disease: Identification of Potential Therapeutic Targets

Gupta S, Singhal NK, Ganesh S, Sandhir R.

CNS Neurol Disord Drug Targets. 2019;18(3):172-184. doi: 10.2174/1871527317666181114163515.

Impact of Antidepressant Use on the Trajectory of Alzheimer's Disease: Evidence, Mechanisms, and Therapeutic Implications

Khoury R, Grossberg GT.

CNS Drugs. 2019 Jan;33(1):17-29. doi: 10.1007/s40263-018-0590-9.

Ethical Issues in the Treatment of Late-Stage Alzheimer's Disease

Watt AD, Jenkins NL, McColl G, Collins S, Desmond PM.

J Alzheimers Dis. 2019;68(4):1311-1316. doi: 10.3233/JAD-180865.

Recent Advances in Multi-target Anti-Alzheimer Disease Compounds (2013 Up to the Present)

Wang N, Qiu P, Cui W, Yan X, Zhang B, He S.

Curr Med Chem. 2019;26(30):5684-5710. doi: 10.2174/0929867326666181203124102.

Tau Abnormalities and the Potential Therapy in Alzheimer's Disease

Almansoub HAMM, Tang H, Wu Y, Wang DQ, Mahaman YAR, Wei N, Almansob YAM, He W, Liu D.

J Alzheimers Dis. 2019;67(1):13-33. doi: 10.3233/JAD-180868.

Stem cell therapies for Alzheimer's disease: is it time?

Wang SM, Lee CU, Lim HK.

Curr Opin Psychiatry. 2019 Mar;32(2):105-116. doi: 10.1097/YCO.0000000000000478.

Death-Associated Protein Kinase 1 as a Promising Drug Target in Cancer and Alzheimer's Disease

Chen D, Zhou XZ, Lee TH.

Recent Pat Anticancer Drug Discov. 2019;14(2):144-157. doi: 10.2174/1574892814666181218170257.

Intranasal Delivery of Nanotherapeutics/ Nanobiotherapeutics for the Treatment of Alzheimer's Disease: A Proficient Approach

Dhas NL, Kudarha RR, Mehta TA.

Crit Rev Ther Drug Carrier Syst. 2019;36(5):373-447. doi: 10.1615/CritRevTherDrugCarrierSyst.2018026762.

A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease

Panza F, Lozupone M, Logroscino G, Imbimbo BP.

Nat Rev Neurol. 2019 Feb;15(2):73-88. doi: 10.1038/s41582-018-0116-6.

A pilot study on the effect of lactoferrin on Alzheimer's disease pathological sequelae: Impact of the p-Akt/PTEN pathway

Mohamed WA, Salama RM, Schaalan MF.

Biomed Pharmacother. 2019 Mar;111:714-723. doi: 10.1016/j.biopha.2018.12.118. Epub 2019 Jan 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias